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Annexin A2Mediates Apical Trafficking of Renal Na-K-2Cl
Cotransporter*
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Background: Regulated membrane expression of the renal furosemide-sensitive Na-K-2Cl cotransporter (NKCC2)
determines essential functions of the kidney.
Results: Annexin A2 (AnxA2) is a new interaction partner of NKCC2 with respect to its adluminal trafficking and
activation.
Conclusion: Discussion focuses on trafficking, membrane association, and phosphorylation of NKCC2 and its cellular ligand
AnxA2.
Significance: AnxA2 is relevant for the activation of NKCC2.
The furosemide-sensitive Na-K-2Cl cotransporter
(NKCC2) is responsible for urine concentration andhelpsmain-
tain systemic salt homeostasis. Its activity depends on traffick-
ing to, and insertion into, the apical membrane, as well as on
phosphorylation of conserved N-terminal serine and threonine
residues. Vasopressin (AVP) signaling via PKA and other
kinases activatesNKCC2. Association ofNKCC2with lipid rafts
facilitates its AVP-induced apical translocation and activation
at the surface. Lipid raft microdomains typically serve as plat-
forms for membrane proteins to facilitate their interactions
with other proteins, but little is knownabout partners that inter-
actwithNKCC2.Yeast two-hybrid screening identified an inter-
action between NKCC2 and the cytosolic protein, annexin A2
(AnxA2). Annexins mediate lipid raft-dependent trafficking of
transmembrane proteins, including the AVP-regulated water
channel, aquaporin 2. Here, we demonstrate that AnxA2, which
binds to phospholipids in a Ca2-dependent manner and may
organize microdomains, is codistributed with NKCC2 to pro-
mote its apical translocation in response to AVP stimulation
and low chloride hypotonic stress. NKCC2 and AnxA2 interact
in a phosphorylation-dependent manner. Phosphomimetic
AnxA2 carrying a mutant phosphoacceptor (AnxA2-Y24D-
GFP) enhanced surface expression and raft association of
NKCC2 by 5-fold upon low chloride hypotonic stimulation,
whereas AnxA2-Y24A-GFP and PKC-dependent AnxA2-
S26D-GFP did not. As the AnxA2 effect involved only non-
phosphorylated NKCC2, it appears to affect NKCC2 traffick-
ing. Overexpression or knockdown experiments further
supported the role of AnxA2 in the apical translocation and
surface expression of NKCC2. In summary, this study identi-
fies AnxA2 as a lipid raft-associated trafficking factor for
NKCC2 and provides mechanistic insight into the regulation
of this essential cotransporter.
The renal furosemide-sensitive Na-K-2Cl cotransporter
(NKCC2)3 resides in the luminal membrane and in apical vesi-
cles of thick ascending limb (TAL) cells and mediates transcel-
lular reabsorption of 30% of the filtered NaCl load (1–3).
Loss-of-function mutations of NKCC2 lead to the antenatal
form of Bartter syndrome with severe salt loss in patients (4, 5).
Genetic deletion of the transporter in mice is lethal due to dra-
matic salt loss and extracellular volume depletion (6), whereas
its overactivitymay contribute to hypertension (7). In viewof its
influence on the urinary concentrating mechanism and sys-
temic salt homeostasis, major efforts have been undertaken in
the past to elucidate its regulation (1–3, 8). Several endocrine
andparacrine stimuli aswell as changes in osmolalitymay influ-
ence surface expression and activity of the cotransporter (3, 8,
9). Vasopressin (AVP) is particularly effective in this respect. It
may enhance TAL transport via its binding to the basolateral
Gs-coupled V2 receptor, cAMP release, and resultant rapid
adjustments of NKCC2 surface expression and function (3, 10,
11). Several functionally relevant phosphoacceptor sites within
the N-terminal domains of NKCC2 have been identified. These
become phosphorylated upon AVP administration and may, in
part, contribute to activating the cotransporter (12–16). At
least two independent kinase pathways are involved. One tar-
gets the conservedN-terminal threonine residues ofNKCC2by
means of multiple interactions of no lysine kinase (WNK) iso-
forms and two homologous Ste20-related kinases, oxidative
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stress-responsive kinase 1 (OSR1), and STE20/SPS1-related
Pro/Ala-rich kinase (SPAK) (14, 15, 17). The other likely
depends on the catalytic activity of protein kinase A (PKA) or
AMP-activated protein kinase and targetsNKCC2 at a different
site (15, 18–20). It is still unclear whether phosphorylation
interferes with NKCC2’s membrane insertion or retrieval (3).
Once expressed on the cell surface, a major proportion of
NKCC2 is found within cholesterol- and glycosphingolipid-en-
riched membrane microdomains or lipid rafts (21, 22). Parti-
tioning of the cotransporter into lipid rafts appears to interfere
with its regulated cellular translocation, including apical traf-
ficking and endocytic retrieval (21–23). Molecular determi-
nants involved in raft-dependent trafficking events have, how-
ever, barely been characterized so far.
Annexins have been shown to mediate lipid raft-dependent
trafficking of several transmembrane proteins (24–26). Mem-
bers of the annexin protein family are known to associate with
membrane phospholipids and facilitate membrane fusion of
cytoplasmic vesicles with the plasma membrane (27–29). One
particular member, annexin A2 (AnxA2), has specific roles in
the kidney, where it mediates cAMP-induced trafficking of
aquaporin 2 in the collecting duct (30). AnxA2 is expressed in
TAL as well, where cAMP-induced fusion of NKCC2-carrying
vesicles with the luminal plasma membrane permits rapid sur-
face recruitment and activation of apically stored NKCC2 (12,
19, 31–34). We assumed a functional relation between AnxA2
and NKCC2 based on our present yeast two-hybrid assay data.
AnxA2 may bind raft lipids to facilitate the clustering of cho-
lesterol and glycosphingolipids and may thereby promote raft
formation and support membrane fusion events, e.g. apical ves-
icles carrying the NKCC2 transporter (35). To do so, AnxA2
may act as a monomer or as a heterotetrameric complex
together with its binding partner, the S100A10 protein (also
termed p11) (27, 36).
Here, we have identified AnxA2 as a component involved in
NKCC2 trafficking. AnxA2 directly and selectively interacts
with the N-terminal cytoplasmic domain of the cotransporter
in its nonphosphorylated state and facilitates the apical trans-
location of NKCC2 in response to activation of TAL transport
capacity by AVP or low chloride hypotonic stimulation.
EXPERIMENTAL PROCEDURES
Animals and Cells—Adult male Sprague-Dawley rats and
Brattleboro ratswith diabetes insipidus (DI; all rats 10–14week
old) received standard diet and tap water ad libitum. DI rats
received an intraperitoneal injection of theV2 receptor agonist,
1-deamino-8-D-arginine vasopressin (dDAVP; 1 g/kg body
weight), or vehicle (0.9% saline; n 8 rats per group). For his-
tochemical analysis, rats were anesthetizedwithNembutal (100
mg/kg body weight); the abdominal cavity opened, and kidneys
were fixed by retrograde perfusion through the abdominal
aorta using 3% paraformaldehyde in PBS (37). Kidneys were
then processed for cryostat and paraffin sectioning. For bio-
chemical studies, rats were anesthetized with isoflurane and
killed by cervical dislocation; kidneys were then removed, dis-
sected into cortical and medullary portions, and processed for
the biochemical evaluation.
Mouse macula densa-derived 1 cells (MMDD1) (38) were
cultured in DMEM/F-12 containing L-glutamine, 10% fetal calf
serum (FCS), and 1% penicillin/streptomycin (37 °C, 5% CO2).
Ratmedullary thick ascending limb cells (raTAL) (39) were cul-
tured in renal epithelial growth medium (Promo Cell) supple-
mented with 1% penicillin/streptomycin at 37 °C 5% CO2.
Human embryonic kidney (HEK293) cells were cultured in
-minimal essential medium (Lonza) supplemented with 5%
FCS and 2 mM L-glutamine (37 °C, 5% CO2). Transient trans-
fection experiments were performed using JetPEI (Polyplus
transfection) according to the manufacturer’s protocol. Low
chloride hypotonic stress was induced in MMDD1 cells or
raTAL cells by treating themwith hypotonic low chloride solu-
tion (25 mM NaHCO3, 0.96 mM NaH2PO4, 0.24 mM Na2HPO4,
5mMKCl, 1.2mMMgSO4, 1mMCaCl2, 5.5mM glucose) for 1 h;
isotonic normal chloride solution was used for control (100
mMNaCl) (40). For cytochemical analysis, cells were fixed with
3% paraformaldehyde in PBS for 15 min at 4 °C or precooled
100% methanol for 5 min at 20 °C. For biochemical studies,
cells were lysed, diluted in 1 Laemmli buffer, and analyzed by
immunoblotting.
Immunohistochemistry—Tissue sections were produced
from paraffin-embedded or frozen material. Paraffin sections
were dewaxed and boiled for 6 min in citrate buffer, pH 6, for
antigen retrieval. Fixed cultured cells were treated for 10min at
room temperature with 0.5% Triton X-100, 1% bovine serum
albumin (BSA) in PBS. The following general blocking step was
performed on tissue sections with 5% skim milk in PBS for 30
min or on cells with 1% BSA in PBS. The respective primary
antibodies were applied overnight at 4 °C and rinsed in PBS,
and suitable secondary Cy2- or Cy3-conjugated antibodies
(Dianova) were then incubated for 1 h. Tissue was then
mounted in glycerol/PBS, and coverslips were mounted on
glass slides with Fluoromount-G (SouthernBiotech) and
viewed in a confocal laser microscope (LSM 5 Exciter, Zeiss).
Tissue Preparation and Fractionation—Renal tissue samples
were homogenized in homogenization buffer (250 mM sucrose,
10 mM triethanolamine, and protease inhibitors, pH 7.5) by
grinding and subsequent ultrasonication. Cell debris and nuclei
were removed by centrifugation at 1,000 g for 15 min at 4 °C.
Protein concentrations of the obtainedpostnuclear lysateswere
determined by the Bradford method using the BCA-protein
assay reagent kit (Pierce). Plasma membrane-enriched frac-
tions were separated by additional centrifugation at 16,000 g
for 30min at 4 °C. The remaining supernatant fractionwas thus
enriched in cytoplasmic structures and vesicles. 50 g of pro-
tein were loaded per lane for immunoblotting.
Isolation of Lipid Rafts by Triton X-100 and Sucrose Gradient
Fractionation—Lipid raft extraction was performed as de-
scribed previously (41). Briefly, outer medullary postnuclear
lysates were centrifuged at 120,000 g for 1 h at 4 °C to obtain
membranes and vesicles. The obtained pellets were resus-
pended in ice-cold homogenization buffer supplemented with
1% Triton X-100 and incubated for 1 h at 4 °C under agitation,
followed by ultracentrifugation at 120,000  g for 1 h at 4 °C.
The resulting pellets containing the detergent-insoluble frac-
tions were resuspended in 2 ml of homogenization buffer with
40% sucrose and overlaid with 5 ml of 30% sucrose and 5 ml 5%
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sucrose to create a discontinuous sucrose gradient required for
floating assay. The gradientwas centrifuged overnight at 40,000
rpm and 4 °C. Twelve 1-ml fractions were removed from the
top of the gradient and analyzed by immunoblotting.
Immunoprecipitation of NKCC2 and AnxA2—NKCC2 and
AnxA2 were immunoprecipitated from medullary lysates or
lipid raft-enriched fractions of the discontinuous sucrose gra-
dient (see above). Anti-NKCC2 (Millipore) or anti-AnxA2
(Santa Cruz Biotechnology) antibodies were coupled to Dyna-
beads according to the manufacturer‘s guidelines (Dynabeads
M-270 Epoxy; antibody coupling kit (Invitrogen)). Lipid raft-
enriched fractions of the floating assay were identified by the
presence of the typical raft proteins such as flotillin-1 and
Tamm-Horsfall protein, pooled, and centrifuged at 40,000 g.
The resulting pellets were dissolved in immunoprecipitation
(IP) buffer (TBS containing 0.5% Tween 20 and proteinase
inhibitor). Postnuclear rat outermedullary lysates (10g/l) or
lipid raft-enriched extracts (5 g/l) were incubated with anti-
body-coupled beads overnight at 4 °C upon gentle agitation.
The beads were washed three times with IP buffer followed by a
stringent washing step (300 mM NaCl in IP buffer). Beads were
boiled in 1 Laemmli buffer to elute the precipitated proteins,
and eluates were analyzed by immunoblotting.
SDS-PAGE and Immunoblotting—For immunoblotting, 30
g of protein or 20 l of immunoprecipitates per lane were
subjected to 10% SDS-PAGE and transferred to nitrocellulose
membranes. The membranes were blocked with 5% skim milk
in PBS, incubatedwith primary antibodies (1 h at room temper-
ature and overnight at 4 °C), washed, incubated with the appro-
priate HRP-conjugated secondary antibodies (DAKO; 1 h at
room temperature), and subjected to chemiluminescence for
signal detection (ECL; Amersham Biosciences). Signals were
quantified by densitometry.
Antibodies—Immunohistochemistry and immunoblotting
steps were performed using the following primary antibodies:
anti-NKCC2 (37, 42); anti-NKCC1/2 (T4;Developmental Stud-
ies Hybridoma Bank); anti-Tamm-Horsfall protein (43); anti-
flotillin-1 (BD Biosciences); anti-transferrin receptor (Santa
Cruz Biotechnology); anti-clathrin (BD Biosciences); anti-
transferrin receptor (Santa Cruz Biotechnology); anti-
AnxA2 (Santa Cruz Biotechnology); anti-phospho-Y24-
AnxA2 (Santa Cruz Biotechnology); anti-S100A10 (Acris);
anti-GFP (Roche Applied Science); anti-GAPDH (Santa
Cruz Biotechnology); anti--tubulin (Sigma), and anti-GST
(Sigma). Immunoprecipitation experiments were performed
using anti-NKCC2 antibody (Millipore) and anti-AnxA2 (Santa
Cruz Biotechnology).
Yeast Two-hybrid—Yeast two-hybrid screening was
performed in an automated interaction-mating-matrix ap-
proach as described (44). DNA coding for two overlapping
N-terminal fragments (AS(40–140) and AS(77–177)) of
human NKCC2 were amplified by PCR using a full-length
clone for human NKCC2 as template (DKFZp686O14110Q
or IRATp970G1058D (ImaGenes)). For generation of bait
plasmids, PCR fragments were cloned into a pBTM117c
yeast expression vector to generate fusion proteins contain-
ing a LexA binding domain and one of the NKCC2 frag-
ments. As a selection marker, the vector contains the
gene for phosphoribosylanthranilate isomerase (trp1), an
enzyme required for tryptophan biosynthesis (45). Haploid
L40ccMATa yeasts were transformed with bait plasmids
and subsequently mated to a matrix of 16,888 individual
L40ccMAT yeast clones transformed with pACT-4 vectors
that code for a set of nonredundant human proteins fused to
a GAL4 activation domain and -isopropylmalate dehydro-
genase (Leu2) as a selection marker. Diploid cells were
grown on SDII media deficient for tryptophan and leucine to
select for the presence of both bait and prey plasmids. Phys-
ical interaction of the NKCC2 fragment with the respective
prey protein results in the reconstitution of the GAL4 tran-
scription factor that drives the expression of (lexAop)4-
HIS3, (lexAop)8-URA3, and -galactosidase reporter genes
and thus allows growth on SDIV selection media lacking
tryptophan, leucine, histidine, and uracil. All clones were
also screened for their -galactosidase activity using LacZ
staining as described previously (46). To increase the strin-
gency of the assay, the SDIV and LacZ approaches were run
in triplicate and evaluated in a blinded fashion. Only clones
that grew three times on SDIV medium and were at least
positive twice for LacZ were considered valid hits. Identified
candidates were subsequently ranked based on their TAL
expression. To this end mRNA serial analysis of gene expres-
sion (SAGE) tags detected in the human nephron segments
were mapped to human coding cDNA sequences. Nephron-
specific SAGE tags were obtained as described previously
(32, 47). Human cDNA data were obtained from ENSEMBL
(48) with the BIOMART tool (49). Using scripting software
developed in-house, we mapped the SAGE tags to the cDNA
and obtained for each gene a score for the nephron parts as
follows: glomerulus; proximal convoluted tubule; proximal
straight tubule; medullary thick ascending limb; cortical
thick ascending limb; distal convoluted tubule; cortical col-
lecting duct; outer medullary collecting duct, total. The ratio
of (MTALCTAL)/total was used to indicate TAL-specific
expression. A list of genes was produced that indicated pos-
itive yeast two-hybrid screening results and a high TAL
expression according to the SAGE tag analysis.
Mass Spectrometry—NKCC2 and control IgG immunopre-
cipitates from lipid raft-enriched outer medullary fractions
were subjected to SDS-PAGE and Coomassie Brilliant Blue
staining. The bands produced by NKCC2 IP were excised, and
the gel plugs were washed and equilibrated with ammonium
bicarbonate in acetonitrile and digested with 0.02 g of trypsin
at 37 °C for 24 h. The resulting peptides were desalted and con-
centrated utilizing the ZipTipC18 (Millipore) technology and
eluted directly onto the MALDI target (Bruker Daltonik) using
-cyano-4-hydroxycinnamic acid as matrix. The subsequent
mass spectrometry (MS) analyses were carried out using a
matrix-assisted laser desorption/ionization time-of-flight mass
spectrometry (MALDI-TOF MS, MALDI-Lift fragment mass-
spectrometry (MALDI-TOF-TOF MS; Bruker)). Calibrated
and annotated spectra were subjected to a database search
(Swiss-Prot) utilizing the Bruker Bio-Tool 3.2 and the Mascot
2.2 search engine, which compare the experimental MALDI-
TOF MS and MALDI-TOF-TOF MS data set with the calcu-
lated peptide masses for each entry into the sequence database
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and use empirically determined factors to assign a statistical
weight to each individual peptide match.
DNA Constructs—Full-length mouse AnxA2 (NM_
007585.3) and S100A10 (NM_009112.2) were amplified from
mouse kidney cDNA using corresponding primer pairs and
cloned into pEGFP-N1 or pGEX-6P1 plasmids for transfection
experiments or binding assays. The complete N-terminal
domain of NKCC2 (coding triplets 1–175; NM_001270617.1)
was amplified from rat kidney cDNA and cloned into pGEX-
6P1 vector. The mutant NKCC2 N-terminal constructs mim-
icking constitutive phosphorylation (substitution of Thr or Ser
for Asp) or dephosphorylation (substitution of Thr or Ser for
Ala) of conserved phosphoacceptor sites (Thr-96, Thr-101,
Thr-114, and Ser-126) as well as mutant AnxA2 constructs
mimicking constitutive phosphorylation (substitution of Tyr-
24 or Ser-26 for Asp) or dephosphorylation (substitution of
Tyr-24 for Ala) were generated using site-directed mutagene-
sis. All constructs were confirmed by sequencing (primer
sequences are available on request).
GST Pulldown—After transformation of Escherichia coli
TOP10 with pGEX-6p1 plasmids containing wild-type or
mutant NKCC2 N termini, bacteria were incubated with 0.2
mM isopropyl -D-thiogalactopyranoside (Thermo Scientific)
for 15 h at room temperature to induce protein expression.
FIGURE 1.NKCC2 is colocalizedwith AnxA2 and S100A10 in TAL. A and B, confocal images of ratmedullary kidney TAL (mTAL) andMDdouble-stainedwith
AnxA2or S100A10 (red) andNKCC2 (green).Merge images shownuclei counterstained inblue; scale bars,20m.NKCC2colocalizationwithAnxA2andS100A10
is observed in mTAL. MD also shows colocalization with more cytoplasmic staining of AnxA2 and S100A10 which is absent from cortical TAL (cTAL). C,
cytoplasmic view of luminal plasma membrane sheets from cultured rat TAL cells (raTAL) with EM immunogold double labeling of NKCC2 (black arrows) and
AnxA2 or S100A10 (white arrowheads); scale bars, 40 nm. All signals are largely restricted to dark areas, whereas light areas show little signal. Below, quantifi-
cation of the individual signals is shown. Data are the means S.D.; *, p 0.05; **, p 0.01. D, same view, with EM immunogold double-labeling of NKCC2
(black arrowheads) and flotillin-1 or transferrin receptor (TFR;white arrowheads); scale bars, 40 nm. AlthoughNKCC2 and flotillin-1 signals are colocalized in the
dark areas, NKCC2 and transferrin receptor showdistinct localization. Below, quantification of the individual signals is shown. Data are themeans S.D.; *, p
0.05; **, p 0.01.
TABLE 1
Results of yeast two-hybrid assay
Yeast two-hybrid assay identified 36 candidate proteins as potential interacting partners with N-terminal fragments of NKCC2. Subsequent ranking of the candidates
according to their expression in the TAL identifies AnxA2 among the proteins with the highest expression levels. Top hits of positive interacting genes of the yeast
two-hybrid screen sorted according to the score indicating the relative TAL expression (last column). This score derives from the cTAL and mTAL SAGE hits. Base count
refers to the cDNA length of the transcript. The 2nd column refers to the Ensemble database gene identifier and 3rd and 4th columns to yeast two-hybrid screening results.
Gene symbol ENSG SDIV repeat LacZ repeat Base count cTALmTAL (cTALmTAL)/base count
ANXA2 ENSG00000182718 3 2 33,299 7,218 0.22
GNL1 ENSG00000229470 3 2 19,612 3,886 0.2
AP2B1 ENSG00000006125 3 3 36,000 4,595 0.13
TLE6 ENSG00000104953 3 2 13,053 1,638 0.13
MAF1 ENSG00000179632 3 2 6,772 845 0.12
MKNK1 ENSG00000079277 3 2 35,399 4,414 0.12
VPS39 ENSG00000166887 3 2 17,646 2,047 0.12
PHTF1 ENSG00000116793 3 2 29,375 3,395 0.12
NDRG4 ENSG00000103034 3 2 62,703 6,654 0.11
HOXC4 ENSG00000198353 3 2 3,768 361 0.1
HAAO ENSG00000162882 3 3 7,043 665 0.09
MUC7 ENSG00000171195 3 2 9,528 649 0.07
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After that, bacteria were lysed with lysozyme (Sigma) and Tri-
ton X-100. Fusion proteins were purified by overnight incuba-
tion of lysates with Glutathione magnetic beads (Pierce) and
subsequent washing of beads in pulldown buffer (50 mM
HEPES, 200 mM NaCl, 10 mM CaCl2, and protease inhibitors,
pH 7.5). HEK293 cells were transfected with wild-type or
mutant pEGFP-N1-AnxA2 or pEGFP-N1-S100A10 or pEGFP-
N1-AnxA1 and harvested in ice-cold pulldown buffer contain-
ing 1% Triton X-100; the resulting HEK293 lysates (10–15
g/l) were incubated with GST fusion protein-coupled beads
at 4 °C overnight upon agitation. The beads were washed three
times with pulldown buffer and boiled once in Laemmli buffer
to elute bound proteins, and the eluates were evaluated by
immunoblotting.
Peptide Spot Arrays—GST-fused N-terminal tails of wild-
type NKCC2 as well as its phosphomimetic or nonphosphomi-
metic mutants (5 nM) were spotted onto nitrocellulose mem-
branes and incubated with 5% skim milk in TBS adjusted with
1%Tween 20 to block unspecific bindings. After that, wild-type
or phospho-AnxA2mutants (Y24D or S26D) or S100A10 (each
0.1 M in blocking solution) were applied overnight at 4 °C.
Interactions were evaluated by immunoblotting using anti-
AnxA2 or anti-S100A10 antibodies. GST was used as negative
control, and AnxA2 or S100A10 was spotted on the membrane
as positive controls.
Rip/Flip Immunoelectron Microscopy—Preparation of
plasma membrane sheets was performed as described (50, 51).
Briefly, raTAL cells were grown to confluence on glass cover-
slips, fixed for 15 min in 0.5% paraformaldehyde/PBS, washed
in PBS, and subsequently inverted on glow-discharged nickel
electron microscopy grids coated with poly-L-lysine. Gentle
pressure was applied to the coverslip for 15 s using a fine pair of
forceps. The coverslips were then lifted, leaving portions of the
upper cell surface adherent to the poly-L-lysine-coated grid.
Membranes were fixed in 2% paraformaldehyde for 20 min at
room temperature. Immunogold labeling of AnxA2, S100A10,
flotillin-1, or transferrin receptor was performed using the
respective primary antibodies and 5- or 10-nmgold-conjugated
secondary antibodies (Abcam). For double-labeling of the grids,
anti-NKCC2 antibody and 5- or 10-nm gold-conjugated sec-
ondary antibody (Abcam) were sequentially applied thereafter.
Grids were then fixed in 2% glutaraldehyde in PBS, contrasted
in 1% aqueous tannic acid and 1% aqueous uranyl acetate,
washed with distilled H2O, and examined by transmission elec-
tron microscopy (EM; Zeiss E905).
RNA Interference—Small interference RNA (siRNA) for
AnxA2 (Santa Cruz Biotechnology) or scramble siRNA (nega-
tive control) was repeatedly transfected (two transfections with
8-h time intervals) in 40–50% confluent raTAL cells using
HiPerFect (Qiagen). After that, cells were grown to confluence
for another 50 h. For a rescue experiment, cells were transiently
transfected with pEGFP-N1-AnxA2 (JetPEI) and incubated for
24 h. Cells were then lysed for RNA isolation followed by quan-
titative real time PCR and immunoblotting evaluations.
mRNA Extraction, cDNA Synthesis, and Quantitative PCR
(qPCR) Analysis—RNA extraction from cellular or tissue
lysates was performed using the TRIzol reagent (Invitrogen)
according to the manufacturer’s protocol, and cDNA was syn-
thesized by reverse transcription (BioScript, Bioline). qPCRwas
performed usingHOTFIREPol EvaGreen qPCRMix Plus (Solis
BioDyne) and primer pairs specific for AnxA2 (NM_007585.3),
NKCC2 (NM_001270618.1), and GAPDH (forward, 5	-tgcac-
caccaactgcttagc-3	; reverse, 5	-ggcatggactgtggtcatgag-3	) in the
Real Time PCR 7500 system (Applied Biosystems). All samples
were determined in triplicate. Threshold cycle (Ct) values were
quantified and normalized against GAPDH (
Ct), and the
calibrator was subtracted (

Ct). Finally, to perform relative
quantification, an exponentiation was calculated by use of 2 to
the power of

Ct (comparative Ctmethod) (52).
Analysis of Data—All values are the means  S.D. Cohorts
were compared with Student’s two-tailed unpaired t test. p 
0.05 was accepted as statistically significant.
RESULTS
Identification of AnxA2 as an Interaction Partner of NKCC2
by a Yeast Two-hybrid Screen—To identify candidates thatmay
interact with NKCC2, we first performed yeast two-hybrid
screens. Baits consisting of two overlapping N-terminal frag-
ments of human NKCC2 were used to screen a human cDNA
library. The choice of the baits was based on the presence of
multiply conserved, functionally relevant NKCC2 phosphoac-
ceptor sites (Thr-100, Thr-105, Thr-118, and Ser-130). Yeast
two-hybrid screening revealed 36 potential interaction partners
of NKCC2 (Table 1). Subsequent ranking of the candidates by
their renal expression levels identified AnxA2 as the product
with the strongest expression in rat and human TAL. Because
annexinsmay serve as trafficking factors for various transmem-
FIGURE 2.NKCC2 and AnxA2 are substantially codistributed in lipid raft-
containing fractions. A and B, detergent-resistantmembrane rafts were iso-
lated from rat kidney medulla after extraction with Triton X-100 and subse-
quent sucrose gradient centrifugation. A, NKCC2, AnxA2, and S100A10
immunoblot signals showed significant codistribution in the lowdensity frac-
tions (framed) along with the raft markers, flotillin-1 and Tamm-Horsfall pro-
tein (THP). Clathrin serves as a marker for non-raft fractions. B, densitometric
analysis of the signals in A. Data are the means S.D.; **, p 0.01.
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brane proteins (29, 53–55), we hypothesized that AnxA2 may
be involved in the trafficking of NKCC2.
Distribution of NKCC2 and AnxA2 in Lipid Rafts—The cel-
lular distribution of AnxA2 was analyzed in rat kidney with a
focus on the TAL. Because we have shown before that traffick-
ing of NKCC2 in TAL depends on its distribution in rafts (21),
we further analyzed its distribution together with AnxA2 in
lipid rafts. Therewas substantial apical colocalization ofAnxA2
with NKCC2 in medullary (m)TAL and macula densa (MD)
cells, whereas cortical (c)TAL exhibited weak or no AnxA2 sig-
nal by confocal microscopy (Fig. 1, A and B). S100A10 protein,
also termed p11 or AnxA2 light chain, mediates protein inter-
actions with AnxA2 in a scaffolding manner (36, 56, 57).
S100A10 was colocalized as well with NKCC2 in mTAL and
MD but was absent from cTAL cells (Fig. 1, A and B). To study
whether these components are also colocalized at a high reso-
lution level and whether they are coexpressed within lipid rafts,
sheets of the apical membrane were obtained from cultured
raTAL cells using the rip/flip technique. We then used EM-
immunogold staining of the sheets and confirmed an intimate
colocalization of AnxA2 and S100A10 with NKCC2 in dark,
electron-dense subdomains. Numerical evaluation confirmed
that signals were largely restricted to the dark domains
throughout (Fig. 1C). To further characterize the distribution
of NKCC2 within the dark domains, which have earlier been
referred to as rafts (51, 58), double staining with the established
raft marker flotillin-1 (59, 60) showed predominant colocaliza-
tion of the two products in the dark domains, whereas the non-
raft protein, transferrin receptor (61, 62), was found outside of
the dark domains in the light surroundings, mostly separated
from NKCC2 signals. Quantitative evaluation underlined that
the majority of NKCC2 signal was restricted to the dark
domains likely to represent lipid rafts (Fig. 1D). To corroborate
these data biochemically, detergent-resistant membrane rafts
were isolated from rat kidney medullary homogenate using
extraction with Triton X-100 and subsequent sucrose gradient
centrifugation. The resulting detergent-insoluble fractions
contained NKCC2, AnxA2, and S100A10 as well as flotillin-1
and another raft protein, glycosylphosphatidylinositol-an-
chored Tamm-Horsfall protein (Fig. 2, A and B) (63). In aggre-
gate, these data thus support a codistribution of AnxA2,
S100A10, and NKCC2 within apical membrane rafts.
FIGURE 3. NKCC2 and AnxA2 physically associate in rafts. A, representative immunoblots showing IP of NKCC2 and AnxA2 from medullary rat kidney
homogenates. AnxA2 and S100A10 co-IP with NKCC2 as bait, and mutually, NKCC2 and S100A10 co-immunoprecipitate with AnxA2 as bait. IgG indicates
control immunoprecipitation with nonspecific IgG. B, immunoblots after NKCC2 IP from Triton X-100-insoluble fractions of discontinuous sucrose gradient
show co-IP band for AnxA2 and S100A10. Flotillin-1 serves as positive raft marker. C, densitometric evaluation of co-immunoprecipitated AnxA2 and S100A10
signals normalized to respective input signals revealed3-fold stronger interaction of NKCC2 with AnxA2 as compared with S100A10. Data are themeans
S.D.; **, p 0.01.D and E,MALDI-TOFmass spectra (left) andMALDI-TOF/TOF-MS/MS spectra (right) obtained bymass spectrometric evaluation of the eluates
afterNKCC2 IP from the insoluble gradient fractions confirm thepresenceofNKCC2 (D) andAnxA2 (E), supporting their physical associationwithin rafts.Arrows
point to NKCC2- or AnxA2-specific peptides (left panels). AU, arbitrary units.
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NKCC2 N Terminus Directly Interacts with AnxA2—Rat
medullary kidney extracts or derived raft-enriched fractions
were used for co-immunoprecipitation (co-IP) experiments to
study potential interactions ofNKCC2withAnxA2or S100A10
(Fig. 3, A–E). These experiments revealed substantial physical
interaction of NKCC2 with AnxA2 but less so with S100A10
(Fig. 3,A–C). To specify interactions at the molecular level, the
recombinant N terminus of NKCC2 and the recombinant,
complete AnxA2 or S100A10 proteins were studied for inter-
action using peptide spot assay (Fig. 4, A–D). Resulting signals
indicated binding between the N terminus of NKCC2 with
AnxA2 but not S100A10 (Fig. 4A). To specify the role of N-ter-
minal NKCC2 phosphorylation (Thr-96, Thr-101, Thr-114,
and Ser-126) in its interaction with AnxA2, phosphomimetic
and nonphosphomimetic mutants were tested in spot assays;
AnxA2 selectively bound to the nonphosphomimetic mutants
(Fig. 4A). These data were confirmed by GST pulldown assays
using the wild-type and mutant N termini of NKCC2 as baits
(Fig. 4, E and F).
Short Term Administration of Vasopressin Increases Surface
Expression and Lipid Raft Association of NKCC2 and AnxA2—
AVP is a potent endocrine activator of NKCC2 that promotes
its apical trafficking (12, 21, 33). To study the effects of AVP on
AnxA2 and S100A10, AVP-deficient Brattleboro rats with cen-
tral DIwere treatedwith theV2 receptor agonist, desmopressin
(dDAVP, 30 min). Immunoblots after tissue fractionation
revealed shifts of AnxA2 and NKCC2 by signal increases in the
plasma membrane-enriched fractions (29% for AnxA2 and
28% forNKCC2) comparedwith decreases in the cytoplasmic
fractions (29% for AnxA2 and 27% for NKCC2; p  0.05);
changes of S100A10 were absent (Fig. 5A). Confocal evaluation
confirmed apical shifting of the AnxA2 signal, whereas the
S100A10 signal was practically unaltered. Because of its strictly
subapical localization at baseline, a shift of NKCC2 to the sur-
face could not be visualized (Fig. 5B). dDAVP further induced
parallel shifts of NKCC2 and AnxA2 into the low density
sucrose gradient fractions from medullary extracts (13% for
NKCC2 and19% for AnxA2; p 0.05), suggesting enhanced
raft association of both products (Fig. 6A). The interaction of
NKCC2withAnxA2was increased 2-fold in the raft fractions as
revealed by co-IP (Fig. 6B). Activation of the V2 receptor thus
concomitantly stimulated luminal trafficking and raft associa-
tion of NKCC2 and AnxA2 and corroborated their interaction.
Because AnxA2 appears to exclusively interact with nonphos-
phorylated NKCC2, we suggest that AVP-induced trafficking
events precede the phosphorylation of the cotransporter.
AnxA2 Facilitates Membrane Recruitment of NKCC2 upon
LowChlorideHypotonic Stress in Cultured Cells—Low chloride
hypotonic stress is an established condition to promote apical
trafficking and surface expression of NKCC2 in heterologous
models (3, 12, 14, 15). We therefore tested whether under this
condition trafficking of endogenous NKCC2 was affected by
the presence of AnxA2 or S100A10. To this end, cultured MD
cells (MMDD1) were transfected with vectors coding for
AnxA2-GFP, S100A10-GFP, or GFP alone and stimulated with
low chloride hypotonic stress for 1 h. Cells were then fraction-
ated, and the resulting plasma membrane pool was further
extracted with cold detergent. The obtained raft fractions
revealedmarkedly increased signals for NKCC2 upon transfec-
tion with AnxA2-GFP (239%; p  0.01), whereas S100A10-
GFP or GFP alone had no effects (Fig. 7, A and B). The specific
role of AnxA2 was further illustrated cytochemically. Upon
stimulation, a clear redistribution from the cytosol to the
plasmamembrane was observed for AnxA2-GFP but less so for
S100A10-GFP, and GFP alone showed no effect (Fig. 7C). Data
therefore suggest that AnxA2 facilitates luminal trafficking and
raft association of NKCC2 upon stimulation. To further illus-
trate the role of AnxA2 in NKCC2 trafficking, AnxA2 defi-
ciency was induced by RNAi-mediated knockdown of its
expression. In contrast toMMDD1 cells, which had low endog-
FIGURE 4. AnxA2 but not S100A10 directly and selectively interact with
nonphosphorylated NKCC2 species. A, representative peptide spot assays
of interactions between the GST-fused, purified N-terminal tails of wild-type
(WT) NKCC2 as well as its phosphomimetic or nonphosphomimetic mutants
with AnxA2 or S100A10. WT and mutant NKCC2 N termini were spotted to
nitrocellulose membranes, incubated with AnxA2 or S100A10, and detected
by specific antibodies to AnxA2 or S100A10. AnxA2 selectively binds to WT
NKCC2 and the nonphosphomimetic mutants. Note the lack of interactions
between WT or mutant NKCC2 N termini and S100A10. B, specificity of the
assays and the lackof antibody cross-reactivitywere tested in control spots.C,
Coomassie Blue staining of recombinant WT AnxA2 and S100A10. D, control
immunoblot of GST-fused recombinant WT NKCC2 N terminus and its phos-
phomimetic and nonphosphomimetic mutants produced in E. coli. E, control
immunoblot showing GFP-tagged AnxA2, S100A10, or AnxA1 produced in
HEK293 cells. F, immunoblots of eluates after GST pulldown assays using
phosphomimetic and nonphosphomimetic NKCC2 mutants as baits and
lysates from HEK293 cells transfected with GFP-tagged AnxA2, S100A10, or
AnxA1 (asterisk). Note strong interactions of AnxA2 with the WT and non-
phosphomimetic NKCC2 mutants but less so with the phosphomimetic
NKCC2 mutants. NKCC2 N termini show no interaction with S100A10 or
AnxA1.
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enous AnxA2 expression, cultured raTAL cells spontaneously
displayed substantial abundance of AnxA2 and were therefore
more suitable. Transfection with AnxA2 siRNA resulted in a
significant knockdown of AnxA2 (67% at the mRNA level;
p 0.01; and77% at the protein level; p 0.01) after 72 h; the
abundance ofNKCC2was unaffected under this condition (Fig.
8,A andB). Low chloride hypotonic stress for 1 h led to efficient
trafficking of NKCC2 to the surface of control cells, whereas in
AnxA2-deficient cells, NKCC2 distribution was unchanged
(Fig. 8C). In addition, control rescue experiments were per-
formed using transient transfection of AnxA2-GFP subsequent
to its knockdown. The resulting overexpression of AnxA2-GFP
markedly increased AnxA2 abundance and normalized the cel-
lular response to the low chloride hypotonic stress (Fig. 8,
A–C).
AnxA2-NKCC2 Interaction Depends on AnxA2 Phosphor-
ylation—Generally, interactions of AnxA2 with other proteins
depend on phosphorylation and/or dephosphorylation at its
Tyr-24 residue or at residues Ser-12 and Ser-26 (24, 57, 64–66).
We have therefore mutated Tyr-24 to mimic its constitutive
phosphorylation (Y24D) or dephosphorylation (Y24A), as well
as Ser-26 tomimic its phosphorylation (S26D), andwe analyzed
these mutants for their ability to interact with NKCC2 in
MMDD1 cells. Compared with control GFP transfection, over-
expression of AnxA2-Y24D-GFP strongly facilitated surface
expression and raft association of NKCC2 in response to low
chloride hypotonic stress for 1 h (510% in Triton-insoluble
fractions of plasma membrane; p  0.05), whereas AnxA2-
S26D-GFP and AnxA2-Y24A-GFP had only minor effects (Fig.
9,A andB). Next, interactions between theAnxA2mutants and
theNKCC2N terminuswere analyzed by peptide spot andGST
pulldown assays using its phosphomimetic and nonphospho-
mimetic mutants (Fig. 10, A–E). As expected, AnxA2-Y24D
readily interacted with the WT NKCC2 N terminus and its
nonphosphomimeticmutants but notwith its phosphomimetic
FIGURE 5. V2 receptor stimulation of rats with diabetes insipidus stimulates trafficking of NKCC2 and AnxA2 but not S100A10. A and B, rats were
analyzed after 30 min of treatment with desmopressin (dDAVP) or vehicle. A, immunoblots of plasmamembrane (pm)-enriched and cytoplasmic (cyt) vesicle
containing fractions from medullary kidney homogenates of dDAVP- or vehicle-treated rats. Note significant dDAVP-induced luminal shifts of AnxA2 and
additional NKCC2 as reflected by their increased signals in the plasma membrane fractions; signals in cytoplasmic fractions are concomitantly decreased.
Distributionof S100A10 signals is unchanged.Data are themeansS.D.; *,p0.05.B, confocal images show increaseof apical AnxA2 signal,whereas S100A10
is unchanged.Merge images show nuclei counterstained in blue; scale bars, 10 m.
FIGURE 6. V2 receptor stimulation enhances the interaction between
AnxA2 and NKCC2 and corroborates their raft association. A, immunob-
lots showing distribution of NKCC2 and AnxA2 along discontinuous sucrose
gradient from the Triton X-100-insoluble fractions obtained from outer med-
ullary (OM) extracts of vehicle- or dDAVP-treatedDI rats. Densitometry shows
significant shifts from the higher (unframed) to the lower density fractions
(red frames). B, immunoblots showing IP of NKCC2 and co-IP of AnxA2 from
the low density fractions. The experiment was controlled by IP using nonspe-
cific IgG. Densitometry of AnxA2-to-NKCC2 signal ratio reflects the strength
of their interaction. The data are the means S.D.; *, p 0.05.
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mutants (Fig. 10, A and D). In contrast, AnxA2-S26D and
AnxA2-Y24A mutants did not exhibit significant interactions
either with WT or mutant N-terminal tails of NKCC2 (Fig. 10,
B andD). These resultswere corroborated by detection of phos-
phorylated AnxA2 with an anti-phospho-Tyr-24-AnxA2 anti-
body (pY24-AnxA2) in eluates fromGST pulldown assays with
rat kidney medulla lysates. Here, the WT NKCC2 N terminus,
as well as themutantsmimicking its dephosphorylation, bound
the phosphorylated AnxA2, whereas no interactions between
the pY24-AnxA2 and the NKCC2 phosphomimetic mutants
were detected (Fig. 10F). Overall, these results suggest that
phosphorylation of AnxA2 at its Tyr-24 residue promotes its
interactionwith dephosphorylatedNKCC2,which in turn facil-
itates the apical trafficking of the transporter.
DISCUSSION
Activity of a cell membrane transporter or channel, such as
NKCC2, principally depends on its surface expression. Our
previous work has shown that the distribution of NKCC2 in
apical lipid rafts facilitates its anterograde trafficking to the cell
surface (21). A role for lipid rafts during endocytic retrieval of
NKCC2 has been suggested as well (22); because clathrin, oth-
erwise relevant for its endocytosis, is not a raft-associated pro-
tein, this process appears to require uncoupling of at least a
proportion of the cell membrane’s NKCC2 pool from clathrin
(67). Partitioning of NKCC2 to rafts thus appears to substan-
tially determine steps of its surface expression and membrane
half-life (21, 23). The detailed impact of NKCC2’s raftophilicity
in the context of its cellular trafficking was, however, little
understood. A potential key to better understand this lies in the
fact that lipid rafts may as well serve as scaffolding platforms to
facilitate interactions ofNKCC2with other proteins involved in
its trafficking (21, 23). Here, we have established AnxA2 as a
permissive element in the apical trafficking and surface expres-
sion of NKCC2, with both products codistributed in lipid rafts.
Furthermore, AnxA2 promoted the association ofNKCC2with
rafts, which was probably related with the known property of
annexins to bind to negatively charged phospholipids, primar-
ily phosphoinositides, and to stabilize lipid rafts (35, 68–70).
Mechanisms of anterograde trafficking of NKCC2 have been
addressed previously. In particular, the role of conserved C-ter-
minalmotifs of NKCC2 have been elucidatedwith respect to its
apical sorting (71–73).Herewehave shown that theN-terminal
tail of NKCC2 is relevant for its surface expression as well, and
that intact trafficking requires a direct interaction of its N-ter-
minal domain with AnxA2. This domain encloses several con-
served, functionally relevant phosphoacceptor sites (13–15). It
has been assumed earlier that phosphorylation of the cotrans-
portermay interfere with its surface expression, although it was
unclear whether NKCC2 becomes phosphorylated before, by
the time of, or after its insertion in the apical membrane (14,
FIGURE 7. Low chloride hypotonic stress enhances raft association of NKCC2 and AnxA2. A, immunoblots showing cellular distribution of transiently
transfectedAnxA2-GFP, S100A10-GFP, andGFP andendogenousNKCC2 inMMDD1cells under normal chloride conditionor lowchloridehypotonic stress; the
cytoplasmic (cyt) and the TritonX-100-soluble (TS) and -insoluble (TI)membrane fractions are shown.Densitometry demonstrates that AnxA2but not S100A10
orGFP are shifted to the Triton-insoluble fraction. GAPDHwasdetected asmarker of the cytoplasmic fractions, and flotillin-1was used as a raftmarker. Data are
themeansS.D.; *,p0.05.B,densitometric quantificationofNKCC2abundance in theTriton-insolublemembrane fraction fromAnxA2-GFP-, S100A10-GFP-,
or GFP-transfected cells kept under normal chloride condition or low chloride hypotonic stress. AnxA2-GFP enhances raft association of NKCC2 more than
S100A10-GFP or GFP alone. Data are the means S.D.; *, p 0.05; **, p 0.01 for differences between low and normal chloride conditions; #, p 0.01 for
differences between the transfections. n.s., no significance. C, confocal images of the transfected MMDD1 cells under the different chloride conditions. Note
increases of plasma membrane-associated AnxA2 (arrowheads) but not of S100A10 signals upon low chloride hypotonic stress; scale bars, 10 m.
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15). Our present data show that, as far as its interaction with
AnxA2 is concerned, trafficking of NKCC2 requires that its
N-terminal residues be nonphosphorylated, which implies that
NKCC2membrane insertion precedes its phosphorylation (Fig.
11). This interpretation agrees with the observation that a pre-
dominant proportion of phosphorylated NKCC2 is localized in
the apical membrane, where it is also colocalizing and interact-
ing with its activating kinases, SPAK andOSR1 (21, 74, 75). The
fact that NKCC2 surface expression was unaltered in trans-
genicmousemodels presenting a dramatic decrease or increase
ofNKCC2phosphorylation such as SORLA-deficient or SPAK-
deficient mice, respectively, further suggests that membrane
insertion of the cotransporter does not require its phosphory-
lation and is thus compatible with AnxA2’s permissive role in
NKCC2 apical trafficking (74–76).
In the context of raft formation and stabilization, AnxA2was
further proposed to direct cytoplasmic vesicles or domains of
organelles to the cytoskeleton to prepare for or to permit their
intracellular translocation (69, 77, 78). The present fine struc-
tural analysis demonstrates colocalization of AnxA2 and
NKCC2 within the same membrane microdomains that were
identified as lipid rafts. Along with the additional biochemical
evidence of their codistribution in lipid rafts and the evidence of
their physical interaction, a role for AnxA2 may as well be sug-
gested in NKCC2 vesicular trafficking. In this respect, cellular
translocation of several other transmembrane proteins, includ-
ing ion transporters and signaling receptors, has been shown to
depend on the availability of or the interaction with AnxA2 (24,
25, 79–81). In particular, AnxA2 was shown to determine
cAMP-induced trafficking of aquaporin 2 (30). Because both
aquaporin 2 and NKCC2 are major targets of AVP (3, 11, 82,
83), AnxA2 appears to have a significant impact in AVP signal-
ing in the two segments harboring these products, TAL and
collecting duct, thereby serving to promote urine concentra-
tion. The observed AVP-induced stimulation of the interaction
intensity between AnxA2 and NKCC2 as well as the pro-
nounced apical shift of AnxA2 upon administration of the
extrinsicAVPagonist dDAVP inAVP-deficientDI rats has pro-
vided additional supporting evidence for this hypothesis (Fig.
11). Because AnxA2 may be functional in its monomeric form
or as a heterotetrameric complex togetherwith its binding part-
ner, protein S100A10, we have testedwhether protein S100A10
FIGURE 8. Knockdown of AnxA2 blunts the low chloride hypotonic stress-induced plasma membrane recruitment of NKCC2. A–C, transfections of
scramble siRNA (control), AnxA2 siRNA (knockdown), and AnxA2 siRNA with subsequent AnxA2-GFP (rescue) in cultured raTAL cells. A, qPCR evaluation.
Relative mRNA values were obtained using the comparative Ct method and normalization to GAPDH expression. Data are the means S.D.; **, p 0.01. B,
immunoblots from raTAL cell lysates and densitometric quantification. Note that NKCC2 abundance was generally unaffected. Tubulin serves as loading
control; **, p 0.01. C, confocal images of transfected raTAL cells kept under normal chloride condition or low chloride hypotonic stress; scale bars, 20 m.
Representative confocal profiles of AnxA2 andNKCC2 signal intensities scored across two neighboring cells (lines) are shown at the right of the corresponding
images. Note that the recruitment of NKCC2 into the plasma membrane under low chloride hypotonic stress was blunted after the AnxA2 knockdown but
normalized by the rescue of AnxA2 (arrowheads).
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plays a role in the present context as well. Our binding assays
demonstrated that, despite the co-distribution of AnxA2, pro-
tein S100A10, and NKCC2 in lipid rafts, the interaction
between AnxA2 and NKCC2 did not require the presence of
protein S100A10. Whereas the physical interaction between
AnxA2 and NKCC2 may facilitate trafficking and partitioning
to rafts, the tetrameric form of AnxA2 may be functional in
stabilizing apical rafts in TALwith the help of protein S100A10
(35, 69, 70, 84, 85).
The N-terminal tail of AnxA2 is a substrate for PKC- and
PKA-induced phosphorylation and dephosphorylation events
(24, 57, 64, 65). Our data indicate that AnxA2 phosphorylation
at Tyr-24 facilitates its interaction with NKCC2, whereas PKC-
induced AnxA2 phosphorylation at Ser-26 rather abolishes
FIGURE 9. Effects of differential AnxA2 phosphorylation on NKCC2 plasma membrane recruitment and lipid raft association in response to low
chloride hypotonic stress. A, confocal images ofMMDD1 cells transiently transfectedwith GFP-tagged AnxA2mutantsmimicking phosphorylation (Y24D or
S26D) as well as dephosphorylation (Y24A) following normal chloride condition or low chloride hypotonic stress. AnxA2-Y24D but not AnxA2-S26D or
AnxA2-Y24A substantially facilitates plasma membrane recruitment of NKCC2 upon low chloride hypotonic stress. B, immunoblots showing abundances of
AnxA2-Y24D, AnxA2-S26D, AnxA2-Y24A, and endogenous NKCC2 in cytoplasmic (cyt) fractions and Triton-soluble (TS) and Triton-insoluble (TI) plasmamem-
brane fractions obtained from lysates ofMMDD1 cells subjected to normal chloride condition or low chloride hypotonic stress. Densitometric quantification of
AnxA2-Y24D,AnxA2-S26D, andAnxA2-Y24A (all fractions) andNKCC2 signals (Triton-insoluble fractions); thedata are themeansS.D.; *,p0.05; **,p0.01,
n.s.,no significance. There is a selective, stronger associationof AnxA2-Y24DandNKCC2with the Triton-insoluble fractions upon lowchloridehypotonic stress.
AnxA2 Regulates Apical NKCC2 Trafficking
APRIL 4, 2014•VOLUME 289•NUMBER 14 JOURNAL OF BIOLOGICAL CHEMISTRY 9993
 at M
A
X
 D
ELBRU
ECK
 CEN
TRU
M
 FU
E on A
pril 8, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
binding of AnxA2 to the transporter. PKA is known to act
upstream of calcineurin and thus mediates dephosphorylation
of AnxA2 at Ser-26 whereby phosphorylation at Tyr-24 could
be promoted (57, 86–88). These results are in line with previ-
ously described stimulatory effects of PKA activation on the
luminal trafficking of NKCC2 (19, 89). It has been shown that
PKA mediates effects of AVP by promoting the anterograde
trafficking, as well as recycling of NKCC2 thus increasing its
surface expression and activity (3, 10, 11). However, the com-
ponents operating downstream of the PKA effects have not
been elucidated so far (3). Here, we show that the AnxA2
mutant mimicking AnxA2 phosphorylation at Tyr-24 strongly
facilitates membrane insertion of NKCC2 upon low chloride
hypotonic stress, whereas the AnxA2 mutants mimicking
Tyr-24 dephosphorylation or PKC-induced Ser-26 phosphor-
ylation have no stimulatory effects on NKCC2 surface expres-
sion. It is therefore tempting to speculate that AnxA2 partici-
pates in stimulated apical trafficking/recycling of NKCC2
downstream of PKA activation. Thus, our data provide several
lines of evidence that AnxA2 is involved in stimulated NKCC2
trafficking. At the same time, our AnxA2 knockdown or over-
expression experiments induced only moderate changes of
steady state NKCC2 surface expression suggesting that AnxA2
is not necessary for baselineNKCC2 function but plays a role in
the rapid membrane recruitment of the transporter upon
stimulation.
Acute increase of NKCC2 surface expression upon appropri-
ate stimulation by AVP or low chloride may involve several
synergistic mechanisms such as promotion of anterograde
NKCC2 trafficking, rapid membrane insertion of NKCC2-con-
taining vesicles from the apical pool, stimulation of NKCC2
recycling, and probably also inhibition of NKCC2 endocytosis
(3, 8, 9). It is currently unclear which one of these processes
depends on AnxA2; however, based on its apical distribution
in TAL cells, its proposed PKA sensitivity, and its known
ability to facilitate the fusion of intracellular vesicles with the
FIGURE 10. Tyr-24 phosphorylation of AnxA2 promotes its direct interaction with NKCC2. A and B, peptide spot assays of interactions between the
GST-fused, purified N-terminal phosphomimetic or nonphosphomimetic NKCC2mutants and AnxA2mutants mimicking its phosphorylation (Y24D or S26D).
NKCC2 mutants were spotted to nitrocellulose membranes, incubated with AnxA2-Y24D (A) or AnxA2-S26D (B), and detected by anti-AnxA2 antibody.
Specificity of the assays and lack of antibody cross-reactivity were verified by detection of the control spots using anti-AnxA2 antibody. A, note that the
AnxA2-Y24D mutant selectively binds to the nonphosphomimetic NKCC2 mutants. B, AnxA2-S26D shows no interactions with either mutant of NKCC2. C,
Coomassie Blue staining of recombinant AnxA2-Y24D and AnxA2-S26D.D, immunoblots of eluates after GST pulldown assays usingWT N terminus of NKCC2
and its phosphomimetic and nonphosphomimetic mutants as baits and lysates from HEK293 cells transfected with either GFP-tagged AnxA2-Y24D, AnxA2-
S26D,AnxA2-Y24A, orAnxA1 (asterisk). There are strong interactionsofAnxA2-Y24Dwith theWTandnonphosphomimeticNKCC2mutants but less sowith the
phosphomimetic mutants. AnxA2-S26D and AnxA2-Y24Amutants show only weak interactions with either NKCC2mutant, whereas AnxA1 does not interact
with NKCC2 N termini in this setting. E, control immunoblot showing GFP-tagged AnxA2 mutants (Y24D, S26D, and Y24A), S100A10, or AnxA1 produced in
HEK293 cells. F,GST pulldown assaywith NKCC2N-terminalmutants and lysates from rat kidneymedulla showing strong interactions of pY24-AnxA2withWT
NKCC2 N terminus and its nonphosphomimetic mutants but not with the phosphomimetic mutants.
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plasmamembrane (24, 57, 64, 66, 77), it may be assumed that
AnxA2 is involved in the rapidly occurring membrane inser-
tion events of apical cytoplasmic vesicles containing NKCC2
(Fig. 11).
In summary, we have identified AnxA2 as a novel factor for
NKCC2 trafficking that facilitates surface expression of the
cotransporter upon stimulation by AVP or low chloride hypo-
tonic stress.While AVP is amajor NKCC2 activating hormone,
low chloride hypotonic stress leads to a decrease in luminal salt
load as it may occur in TAL during physiologic fluctuations or
pathophysiologic perturbations. We therefore believe that
AnxA2 is involved in the dynamic adjustment of TAL transport
function in response to endocrine stimuli or changes in luminal
chloride load.
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